Hygeia Healthcare Holdings Co., Limited (Hygeia Health) disclosed that it repurchased 377,000 ordinary shares on 20 May 2026 via on-exchange transactions.

• Price details: The shares were bought back at prices ranging between HKD 10.56 and HKD 10.64, giving a volume-weighted average cost of HKD 10.61 per share and bringing total cash outlay to HKD 3.99 million.

• Impact on share capital: – Outstanding shares (excluding treasury) fell 0.06% to 612.60 million. – Treasury stock increased to 5.90 million shares. – Total issued shares remained unchanged at 618.50 million, as the repurchased shares have been retained as treasury shares rather than cancelled.

• Repurchase mandate utilisation: – Shareholders authorised management on 27 June 2025 to buy back up to 61.85 million shares. – Cumulative repurchases under this mandate now stand at 5.90 million shares, representing 0.95% of the company’s issued share count on the mandate date, indicating ample remaining headroom.

• Post-repurchase restrictions: In line with Hong Kong listing rules, Hygeia Health is subject to a moratorium on issuing new shares or disposing of treasury shares until 19 June 2026.

All transactions were executed in compliance with the Listing Rules of The Stock Exchange of Hong Kong and relevant regulatory requirements, as confirmed by the company’s board.